Trace Neuroscience is a biopharmaceutical company on a mission to expand the promise of genomic medicine for people living with neurodegenerative diseases. With an initial focus on ALS, the company is developing novel therapies to restore UNC13A protein function to re-establish healthy communication between nerves and muscle cells.
Market
Neurodegenerative diseases
Location
South San Francisco,
California,
USA
Coinvestors
Third Rock Ventures, Atlas Venture, GV, RA Capital Management